Matthew W. VanBrocklin, Ph.D.
Languages spoken:
English
Academic Information
Departments:
Surgery - Associate Professor, Oncological Sciences - Adjunct Assistant Professor
Divisions:
General Surgery
Research Interests
- Molecular Targets
- Melanoma
- Carcinoma, Non-Small-Cell Lung
Matthew VanBrocklin, PhD, is an assistant professor in the Department of Surgery at the University of Utah Hospital, an investigator at the Huntsman Cancer Institute (HCI), and a member of the Cell Response and Regulation program.
At HCI, VanBrocklin researches novel therapeutic targets and signal transduction pathways (networks inside a cell that transmit outside signals to influence cellular responses) that are important for increasing survival in melanoma, non-small cell lung cancer (NSCLC), and brain tumors. He also aims to develop novel small peptide-based agents directed at therapeutic targets that are currently considered "undruggable".
Before joining HCI, VanBrocklin was a researcher at the Nevada Cancer Institute, where he completed a postdoctoral fellowship, established his own lab, and became a member of the Drug Development Division. He received a PhD in biomedical science from Western Michigan University in Kalamazoo, Michigan.
Education History
Postdoctoral Fellowship |
Nevada Cancer Institute
|
Postdoctoral Fellow |
Doctoral Training |
Western Michigan University
Biomedical Science
|
Ph.D. |
Graduate Training |
Mayo Graduate School
Immunology
|
M.S. |
Undergraduate |
Western Michigan University
Biomedical Science/Chemistry
|
B.S. |
Other Training |
Bay de Noc Community College
|
|